Mobic, Meloxicam Newswire

Mobic, Meloxicam Newswire

Comprehensive Real-Time News Feed for Mobic, Meloxicam (generic).

Results 1 - 20 of 40 in Mobic, Meloxicam (generic)

  1. A Look At Recro Pharma Inc (REPH) and Alkermes Plc (ALKS)'s Topline TriumphRead the original story w/Photo

    Wednesday | Insider Monkey

    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. We only allow registered users to use ad blockers.

    Comment?

  2. Recro Pharma's intravenous painkiller succeeds in trial, shares soarRead the original story w/Photo

    Wednesday | Fox News

    Recro Pharma Inc said an intravenous version of its lead painkiller was successful in the first of two pivotal late-stage trials, sending the company's shares surging 50 percent in trading after the bell. The drug, Meloxicam, was being evaluated to treat acute pain in patients after a bunionectomy surgery, which involves removing or realigning soft tissue and bones in the joint of the big toe.

    Comment?

  3. Recro Pharma Shares Rocket as Intravenous Painkiller Succeeds in Phase III TrialRead the original story

    Tuesday Jul 26 | BioSpace

    Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings that is currently developing non-opioid products for the treatment of serious acute pain, today announced positive results from its Phase III clinical trial evaluating intravenous meloxicam for the treatment of acute postoperative pain in patients following bunionectomy surgery. In the trial, IV meloxicam achieved the primary endpoint of a statistically significant difference in Summed Pain Intensity Difference over the first 48 hours compared to placebo.

    Comment?

  4. Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV MeloxicamRead the original story w/Photo

    Tuesday Jul 26 | GlobeNewswire

    Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings that is currently developing non-opioid products for the treatment of serious acute pain, today announced positive results from its Phase III clinical trial evaluating intravenous meloxicam for the treatment of acute postoperative pain in patients following bunionectomy surgery. In the trial, IV meloxicam achieved the primary endpoint of a statistically significant difference in Summed Pain Intensity Difference over the first 48 hours compared to placebo.

    Comment?

  5. Recro Pharma Appoints As Chief Financial OfficerRead the original story

    Monday Jul 4 | BioSpace

    Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today announced the appointment of Michael Celano as Chief Financial Officer, effective July 5, 2016. "Mike is an accomplished financial executive with significant expertise in the biopharmaceutical industry, and we are delighted that he has decided to join the Recro team in this key executive role," said Gerri Henwood, Recro Pharma's President and Chief Executive Officer.

    Comment?

  6. Arthritis in cats difficult to diagnose, treatRead the original story w/Photo

    May 30, 2016 | Northwest Florida Daily News

    Most dog owners are aware that as their pets age they can get arthritis. But what about our cats? We are starting to see more arthritis in cats.

    Comment?

  7. President's NotesRead the original story w/Photo

    May 27, 2016 | Sheep Industry News

    Burton Pfliger, ASI President I hope your spring season has been productive and the weather cooperative on your operation. It's a busy time of year for farmers and ranchers and it seems to be just as busy on the association front anymore.

    Comment?

  8. Is an electric collar the best way to stop my dog from barking?Read the original story w/Photo

    May 22, 2016 | Stuff.co.nz

    Our neighbours have complained about our terrier-cross barking when we leave him at home. Should we rent an electric collar to give him a small shock when he barks? There can be a number of reasons for a dog to bark when he is alone.

    Comment?

  9. Monthly News Roundup - October 2015Read the original story w/Photo

    Oct 29, 2015 | Drugs.com

    Onivyde is a liposomal formulation of the topoisomerase I inhibitor irinotecan approved for treatment of metastatic pancreatic cancer already treated with gemcitabine-based chemotherapy. Onivyde is given in combination with fluorouracil and leucovorin.

    Comment?

  10. Metacam, an injection pain relief drug, is now on the market for treating sheep. | file photoRead the original story

    May 19, 2016 | The Western Producer

    Veterinarians have long prescribed the non-steroidal anti-inflammatory drug meloxicam to sheep, but it wasn't a labelled use. Boehringer Ingelheim and regulatory bodies from Canada, New Zealand and Australia participated in a collaborative review process and have determined that the drug is market ready.

    Comment?

  11. New Data Shows that VIVLODEXA Reduces Rescue Medication Use in Patients with Osteoarthritis PainRead the original story

    May 12, 2016 | Freshnews

    Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that new data from a Phase 3 study in patients with osteoarthritis pain demonstrated patients treated with VIVLODEX capsules consistently used less rescue pain medication, regardless of time of day, compared to patients receiving placebo. VIVLODEX is a low-dose SoluMatrix nonsteroidal anti-inflammatory drug that was approved by the U.S. Food and Drug Administration in October 2015 for the management of osteoarthritis pain.

    Comment?

  12. Iroko Pharmaceuticals Release: New Data Shows That VIVLODEX Reduces...Read the original story

    May 11, 2016 | BioSpace

    VIVLODEX is a low-dose SoluMatrixA nonsteroidal anti-inflammatory drug that was approved by the U.S. Food and Drug Administration in for the management of osteoarthritis pain.1 VIVLODEX dose strengths 5 and 10 mg are 33 percent lower than other currently available oral meloxicam products. Patients receiving VIVLODEX 5 mg and 10 mg used significantly less total rescue medication, took fewer daily doses of rescue medication and for fewer days compared with patients receiving placebo.

    Comment?

  13. Recro Pharma Presents Clinical Data At American Pain Society 35th Annual Scientific MeetingRead the original story

    May 11, 2016 | BioSpace

    Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company developing non-opioid products for the treatment of serious acute pain, today announced a poster presentation at the American Pain Society's 35th Annual Scientific Meeting, taking place May 11-14, 2016, in Austin, TX. The poster presentation highlights data from a clinical trial evaluating the efficacy and safety of intravenous meloxicam , in subjects with moderate to severe pain following open abdominal hysterectomy.

    Comment?

  14. Recro Pharma Reports First Quarter 2016 Financial ResultsRead the original story w/Photo

    May 12, 2016 | GlobeNewswire

    Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings that is currently developing non-opioid products for the treatment of serious acute pain, today reported financial results for the first quarter ended March 31, 2016. "During the first quarter of 2016, we advanced our lead program, intravenous meloxicam into pivotal Phase III clinical development for the treatment of acute postoperative pain - one trial in patients following bunionectomy surgery and one trial in patients following abdominoplasty surgery," said Gerri Henwood, Recro Pharma's President and Chief Executive Officer.

    Comment?

  15. Post-Operative Pain Global Clinical Trials Review Key Trends, Size,...Read the original story

    Apr 20, 2016 | Emailwire.com

    Researchmoz added Most up-to-date research on "Post-Operative Pain Global Clinical Trials Review, H1, 2016" to its huge collection of research reports. Post-Operative Pain Global Clinical Trials Review, H1, 2016" provides an overview of Post-Operative Pain clinical trials scenario.

    Comment?

  16. Choice of pain medication depends on many factorsRead the original story w/Photo

    Apr 17, 2016 | Northwest Florida Daily News

    I was reading an article about osteoarthritis in dogs aging. They mentioned a non-steroid drug for long term treatment called Rimadyl.

    Comment?

  17. to Your Good Health: Too early to tell on arthritis therapyRead the original story w/Photo

    Apr 9, 2016 | SouthCoastToday.com

    DEAR DR. ROACH: My mother is in her mid-60s and was diagnosed with osteoarthritis of the thumb last year.

    Comment?

  18. Dr. Roach: PRP injections may be future therapy for arthritisRead the original story w/Photo

    Apr 4, 2016 | Lubbock Avalanche-Journal

    Dear Dr. Roach: My mother is in her mid-60s and was diagnosed with osteoarthritis of the thumb last year. She is in good health.

    Comment?

  19. Iroko Pharmaceuticals To Present Phase 3 VIVLODEX Efficacy And Safety Data AtRead the original story

    Mar 30, 2016 | BioSpace

    This includes an analysis from the first pivotal efficacy and safety study that supported US approval as well as the combined safety data from two Phase 3 studies. These analyses will be presented at the upcoming 2016 Osteoarthritis Research Society International World Congress on Osteoarthritis being held "We look forward to sharing new data about VIVLODEX, our third low dose SoluMatrixA NSAID and second treatment option for patients with osteoarthritis pain," said Dr. , LLC. "VIVLODEX, and our portfolio of low dose NSAIDs were designed to provide patients and clinicians with options in line with recommendations by the FDA and leading professional organizations to use the lowest effective NSAID dose for the shortest possible duration."

    Comment?

  20. Pet Q and a: Your dog has been diagnosed with arthritis. You may be...Read the original story w/Photo

    Mar 4, 2016 | NorthJersey.com

    Q: Your dog has been diagnosed with arthritis. You may be wondering: What actions can I take to help make my pet more comfortable? What are natural options for treatment? Osteoarthritis is a common degenerative disease of the joints found in many older dogs.

    Comment?